NTZ trials for cryptosporidiosis.
Smart
T
T
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy*; D000328:Adult; D000923:Anticestodal Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002648:Child; D017321:Clinical Trials, Phase I as Topic; D017322:Clinical Trials, Phase II as Topic; D003457:Cryptosporidiosis / Q000150:complications / Q000188:drug therapy*; D003967:Diarrhea / Q000150:complications / Q000188:drug therapy; D006801:Humans; D009574:Nitro Compounds; D013844:Thiazoles / Q000009:adverse effects / Q000627:therapeutic use*
D000923:Anticestodal Agents; D009574:Nitro Compounds; D013844:Thiazoles; C041747:nitazoxanide